Addictions, Drug & Alcohol Institute

ADAI SYMPOSIUM: HIGH-THC CANNABIS IN LEGAL REGULATED MARKETS

REGISTER NOW and join us September 16th (in-person or virtual) for this day-long event focused on the short and long-term risks of high-THC cannabis products, featuring international, national, and regional experts.

NEW LOOK FOR STOPOVERDOSE.ORG

StopOverdose.org has a new look, with improved navigation and organization, better accessibility, and translation into 20 languages (by Google Translate). Learn how to prevent, identify, and reverse an overdose!

CENTER FOR ADVANCING ADDICTION HEALTH SERVICES (CAAHS)

Directed by Bryan Hartlzer and Denna Vandersloot, CAAHS works to increase adoption and implementation of useful treatment and recovery practices by health organizations that serve people with substance use disorders.

PARENT-CHILD ASSISTANCE PROGRAM

NEW LOOK! Learn about the Fetal Alcohol & Drug Unit’s award-winning home visitation case-management model for mothers on their newly redesigned website!

WASHINGTON STATE DATA & RESOURCES

Find statewide or county-specific information about substance use and related topics in Washington State on our newly updated Data & Resources page.

News & Events

Havana McElvaine

Recovery is Health, Health is Recovery: Webinar Series This September

September is National Recovery Month, which celebrates those in recovery from substance use disorders and recognizes the dedicated workers who provide prevention, treatment, and recovery support services for those in need. In addition, Recovery Month also provides an...

Havana McElvaine

Webinar: Washington State Overdose Death Trends, Sept. 20, 12pm PT

Join ADAI's Dr. Caleb Banta-Green (Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER)) on September 20, 2022 (12-1pm PT) for a webinar about overdose death trends, including fentanyl, in Washington State. Dr. Banta-Green will...

Havana McElvaine

ADAI’s “Meds First” Study Highlighted in Seattle Times Editorial

An editorial by the Seattle Times on August 25, 2022 featured information about the community-based “Meds First” buprenorphine study led by the UW Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER) at ADAI. The...